AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $22,299,000 | +64.4% | 330,652 | +12.4% | 0.03% | +47.4% |
| Q4 2018 | $13,566,000 | -25.5% | 294,192 | +24.7% | 0.02% | -9.5% |
| Q3 2018 | $18,198,000 | +18.0% | 235,975 | +28.9% | 0.02% | +16.7% |
| Q2 2018 | $15,426,000 | +16.0% | 183,135 | +12.6% | 0.02% | +5.9% |
| Q1 2018 | $13,295,000 | +63.4% | 162,583 | +14.3% | 0.02% | +70.0% |
| Q4 2017 | $8,134,000 | +567.8% | 142,283 | +679.7% | 0.01% | +900.0% |
| Q3 2017 | $1,218,000 | – | 18,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |